MH004 Ointment

DRUG2 trials

Sponsors

Minghui Pharmaceutical (Hangzhou) Ltd

Conditions

Atopic Dermatitis (AD)Vitiligo

Phase 2

Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo

Active, not recruitingNCT07181187

Minghui Pharmaceutical (Hangzhou) LtdVitiligo

Start: 2024-03-26End: 2026-05-14Updated: 2025-09-18

Phase 3

A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic Dermatitis

CompletedNCT07185282

Minghui Pharmaceutical (Hangzhou) LtdAtopic Dermatitis (AD)

Start: 2023-06-10End: 2025-08-15Updated: 2025-09-22